News

ELCC: Survey reveals worldwide underuse of EGFR-mutation testing


 

AT ELCC 2015

References

The survey was sponsored by Boehringer Ingelheim. Dr. Spicer has been an advisor to and speaker on behalf of Boehringer Ingelheim and had received research funding from the company. Dr. Mok has been a consultant to and speaker on behalf of Boehringer Ingelheim as well as several other drug companies.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages